메뉴 건너뛰기




Volumn 66, Issue SUPPL. 3, 2007, Pages

Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): What do these concepts mean?

Author keywords

[No Author keywords available]

Indexed keywords

ANKYLOSING SPONDYLITIS; CONFERENCE PAPER; HUMAN; OSTEOARTHRITIS; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 35648958865     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.079798     Document Type: Conference Paper
Times cited : (306)

References (13)
  • 1
    • 11844294054 scopus 로고    scopus 로고
    • It's good to feel better but it's better to feel good
    • Dougados M. It's good to feel better but it's better to feel good. J Rheumatol 2005;32:1-2.
    • (2005) J Rheumatol , vol.32 , pp. 1-2
    • Dougados, M.1
  • 2
    • 19944427129 scopus 로고    scopus 로고
    • Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: The minimal clinically important improvement
    • Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, et al. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis 2005;64:29-33.
    • (2005) Ann Rheum Dis , vol.64 , pp. 29-33
    • Tubach, F.1    Ravaud, P.2    Baron, G.3    Falissard, B.4    Logeart, I.5    Bellamy, N.6
  • 4
    • 26444586133 scopus 로고    scopus 로고
    • Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: Methodological issues
    • Tubach F, Wells GA, Ravaud P, Dougados M. Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues. J Rheumatol 2005;32:2025-9.
    • (2005) J Rheumatol , vol.32 , pp. 2025-2029
    • Tubach, F.1    Wells, G.A.2    Ravaud, P.3    Dougados, M.4
  • 5
    • 0035112517 scopus 로고    scopus 로고
    • Minimal clinically important difference module: Summary, recommendations, and research agenda
    • Wells G, Anderson J, Beaton D, Bellamy N, Boers M, Bombardier C, et al. Minimal clinically important difference module: summary, recommendations, and research agenda. J Rheumatol 2001;28:452-4.
    • (2001) J Rheumatol , vol.28 , pp. 452-454
    • Wells, G.1    Anderson, J.2    Beaton, D.3    Bellamy, N.4    Boers, M.5    Bombardier, C.6
  • 6
    • 34248664953 scopus 로고    scopus 로고
    • Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders
    • Tubach F, Ravaud P, Beaton D, Boers M, Bombardier C, Felson DT, et al. Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders. J Rheumatol 2007;34:1188-93.
    • (2007) J Rheumatol , vol.34 , pp. 1188-1193
    • Tubach, F.1    Ravaud, P.2    Beaton, D.3    Boers, M.4    Bombardier, C.5    Felson, D.T.6
  • 7
    • 33846999309 scopus 로고    scopus 로고
    • Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis
    • Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 2007;57:133-9.
    • (2007) Arthritis Rheum , vol.57 , pp. 133-139
    • Maksymowych, W.P.1    Richardson, R.2    Mallon, C.3    van der Heijde, D.4    Boonen, A.5
  • 8
    • 35648992105 scopus 로고    scopus 로고
    • Levels of patient acceptable symptom state for disease activity and health status measures in patients with rheumatoid arthritis (RA) [abstract]
    • Heiberg T, Kvien TK, Mowinckel P, Aletaha D, Smolen J, Hagen KB. Levels of patient acceptable symptom state for disease activity and health status measures in patients with rheumatoid arthritis (RA) [abstract]. Ann Rheum Dis 2007;66(Suppl II):72.
    • (2007) Ann Rheum Dis , vol.66 , Issue.SUPPL. II , pp. 72
    • Heiberg, T.1    Kvien, T.K.2    Mowinckel, P.3    Aletaha, D.4    Smolen, J.5    Hagen, K.B.6
  • 10
    • 19944427011 scopus 로고    scopus 로고
    • Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: The patient acceptable symptom state
    • Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005;64:34-7.
    • (2005) Ann Rheum Dis , vol.64 , pp. 34-37
    • Tubach, F.1    Ravaud, P.2    Baron, G.3    Falissard, B.4    Logeart, I.5    Bellamy, N.6
  • 11
    • 33845481626 scopus 로고    scopus 로고
    • Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis
    • Tubach F, Pham T, Skomsvoll JF, Mikkelsen K, Bjorneboe O, Ravaud P, et al. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis. Arthritis Rheum 2006;55:960-3.
    • (2006) Arthritis Rheum , vol.55 , pp. 960-963
    • Tubach, F.1    Pham, T.2    Skomsvoll, J.F.3    Mikkelsen, K.4    Bjorneboe, O.5    Ravaud, P.6
  • 12
    • 35648948014 scopus 로고    scopus 로고
    • Evaluation of patient acceptable symptom state (PASS) concept: Experience from the ATLAS trial in ankylosing spondylitis (AS) [abstract]
    • Dougados M, Luo M, Maksymowych W, Chmiel J, Chen N, Wong R, et al. Evaluation of patient acceptable symptom state (PASS) concept: experience from the ATLAS trial in ankylosing spondylitis (AS) [abstract]. Ann Rheum Dis 2007;66(Suppl II):73.
    • (2007) Ann Rheum Dis , vol.66 , Issue.SUPPL. II , pp. 73
    • Dougados, M.1    Luo, M.2    Maksymowych, W.3    Chmiel, J.4    Chen, N.5    Wong, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.